COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

Published:2021-01-04 Issue:2 Volume:16 Page:281-308
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Bartoli Alessandra,Gabrielli Filippo,Alicandro Tatiana,Nascimbeni Fabio,Andreone Pietro

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11739-020-02569-9.pdf

Reference80 articles.

1. Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection—a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 9(1):727–732

2. Siddiqi HK, Mandeep RM (2020) COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 39(5):405–407

3. Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847

4. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, Paolini A (2020) Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 11(1):1–17

5. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, Akdis CA (2020) Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 75(7):1564–1581

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Phenotyping for Prognosis and Immunotherapy Guidance in Bacterial Sepsis and COVID-19;Critical Care Explorations;2024-09

2. Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication;Antiviral Research;2024-08

3. Takotsubo syndrome as an outcome of the use of checkpoint inhibitor therapy in patients with COVID-19;Biochemical Pharmacology;2024-08

4. Effect of Maraviroc and/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: clinical trial;F1000Research;2024-06-11

5. Efficacy of lignocaine nebulization in patients with COVID-19 respiratory infection: An exploratory randomized double-blinded controlled trial;Journal of Anaesthesiology Clinical Pharmacology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3